A cure and a bargain?
Results from a new Massachusetts Health Policy Commission report.
Specialty pharmacy has reached an “inflection point” with the power to change the entire industry model.
Finalized rule is a step toward increasing drug pricing transparency.
Rebates for prescription drugs are under scrutiny and attack in both the political and healthcare arenas. But what will happen if drug rebates go away?
The average price of generics is about one-eighteenth the price of the brand product.
Advocates are calling for government regulations on PBMs and pharmacy.
Aggregated data highlights manufacturers responsible for price increases.
Beginning January 2020, all new employer clients must incorporate Point-of-Sale discounts.
Eli Lilly creates generic Humalog priced 50% lower